| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/11/2002 | WO2000056762A3 Methods for monitoring multiple gene expression |
| 07/11/2002 | WO2000049937A9 Trpm-2 antisense therapy |
| 07/11/2002 | US20020092041 Nucleotide sequences coding polypeptide for use in the generation of disease resistant plants. |
| 07/11/2002 | US20020092035 Cell cultures for use in monitoring preferential gene expression in cells |
| 07/11/2002 | US20020092034 Non-human model of gestational and adult folate deficiency and uses thereof |
| 07/11/2002 | US20020091250 Metabotropic GABA [B] receptors, receptor-specific ligands and their uses |
| 07/11/2002 | US20020091249 Human tumor suppressor polypeptides |
| 07/11/2002 | US20020091248 Nucleotide sequences coding polypeptide for use in the treatment of Bardet-Biedl Syndrome, hearing loss, retinis pigmentosa, obesity, hypogonadism, diabetes and cardiovascular disorders |
| 07/11/2002 | US20020091247 Polycyclic aromatic hydrocarbon induced molecules |
| 07/11/2002 | US20020091246 Dendritic cell co-stimulatory molecules |
| 07/11/2002 | US20020091244 Nucleotide sequences for use in diagnosis and treatment of cancer and immunological disorders |
| 07/11/2002 | US20020091239 Human chemokine |
| 07/11/2002 | US20020091238 Nuclelotide sequences coding transport protein for use in treatment of cancer, pain, aberrant cellular proliferation and/or differentiation, hormonal and liver disorders |
| 07/11/2002 | US20020091237 Polypeptide for use in the detection and screenng of batericides |
| 07/11/2002 | US20020091236 Nucleotide sequences coding preferential polypeptide for use in detection of bactericides |
| 07/11/2002 | US20020091235 St - B17 serotonin receptor |
| 07/11/2002 | US20020091234 Adjuvant for enhancing immune response to preferential immunogen |
| 07/11/2002 | US20020091096 Nucleic acid, including DNA, immunization against disease caused by infection by a strain of Chlamydia employing a vector, containing a nucleotide sequence encoding a lorf2 protein of a strain of Chlamydia |
| 07/11/2002 | US20020091086 Peptides that block viral infectivity and methods of use thereof |
| 07/11/2002 | US20020091085 Src SH3 binding peptides and methods of isolating and using same |
| 07/11/2002 | US20020091083 Substance which regulates the type-I collagen gene transcription regulating ability |
| 07/11/2002 | US20020091080 OBG3 globular head and uses thereof for decreasing body mass |
| 07/11/2002 | US20020091079 An empty sc-MHC class II molecule comprising a peptide binding groove and a class II beta 2 chain comprising at least one amino acid substitution or deletion; immunosuppressants |
| 07/11/2002 | US20020091077 Osteogenic protein is provided alone or dispersed in a biocompatible non-rigid, amorphous carrier having no defined surfaces |
| 07/11/2002 | US20020091076 Staphylokinase derivatives |
| 07/11/2002 | US20020090725 Collagen; for use in forming tissues and organs |
| 07/11/2002 | US20020090717 Cell lines and constructs useful in production of E1-deleted adenoviruses in absence of replication competent adenovirus |
| 07/11/2002 | US20020090711 Generating blood glycoprotein; obtain solution containing glycoprotein, incubate in preferential buffer, recover processed glycoprotein |
| 07/11/2002 | US20020090710 57800, a novel human cadherin and uses thereof |
| 07/11/2002 | US20020090708 DNA encoding tumor necrosis factor stimulated gene 6 (TSG-6) |
| 07/11/2002 | US20020090706 Nucleotide sequences coding polypeptides for the use in the treatment of cancer, autoimmune disease and cardiovascular disorders |
| 07/11/2002 | US20020090698 Recombinant process for the production in pseudomonas putida of the cytochrome c551 of pseudomonas aeruginosa |
| 07/11/2002 | US20020090696 Treating neurological disorders using human apoptosis inhibiting protein |
| 07/11/2002 | US20020090695 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies |
| 07/11/2002 | US20020090694 Human Hox C10 and polynucleotides encoding |
| 07/11/2002 | US20020090693 Novel human sodium-dependent phosphate cotransporter |
| 07/11/2002 | US20020090692 Novel polynucleotides and polypeptides encoded thereby |
| 07/11/2002 | US20020090691 Nucleotide sequences coding membrane protein for use in the diagnosis, treatment and prevention of infections |
| 07/11/2002 | US20020090685 Nucleotide sequences coding for the ndkA gene |
| 07/11/2002 | US20020090683 Tumor necrosis factor-gamma |
| 07/11/2002 | US20020090682 Novel haemopoietin receptor and genetic sequences encoding same |
| 07/11/2002 | US20020090681 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/11/2002 | US20020090680 Novel IL-9/IL-2 receptor-like molecules and uses thereof |
| 07/11/2002 | US20020090679 Lung growth factor variant |
| 07/11/2002 | US20020090678 Generating preferential polypeptide; obtain cells, incubate with expression vector containing preferential gene, express vector, recover polypeptide |
| 07/11/2002 | US20020090677 Secreted salivary zsig63 polypeptide |
| 07/11/2002 | US20020090676 TNF receptors, TNF binding proteins and DNAs coding for them |
| 07/11/2002 | US20020090674 Nucleic acids, proteins, and antibodies |
| 07/11/2002 | US20020090673 Nucleic acids, proteins, and antibodies |
| 07/11/2002 | US20020090672 Nucleic acids, proteins, and antibodies |
| 07/11/2002 | US20020090671 Bone stimulating factor |
| 07/11/2002 | US20020090660 Helicobacter pylori antigens in blood |
| 07/11/2002 | US20020090658 Diagnosing connective tissue defects; obtain sample, screen sample for the presence of degradation protein, amplified concentrations of protein indicate connective tissue defects |
| 07/11/2002 | US20020090657 Detecting preferential binding particle in sample; obtain cell, incubate with modulator, monitor forming of complex, compare to control, reduction in complex formation indicates bound receptor |
| 07/11/2002 | US20020090654 Polypeptide for use in the treatment of collagenase defects |
| 07/11/2002 | US20020090651 Isolated FGF receptor |
| 07/11/2002 | US20020090647 Peptide for use in treatment of nervous system disorders |
| 07/11/2002 | US20020090646 Calcitonin-related molecules |
| 07/11/2002 | US20020090632 Measuring the concentration of preferential analyte in sample; obtain samples, incubate with binding particles, determine concentration of detectable particles |
| 07/11/2002 | US20020090622 Detection of a polymorphism in a sodium transport protein; obtain sample, recover nucleotide sequences from sample, determine nucleotide sequences of sample, compare to control |
| 07/11/2002 | US20020090610 Polypeptide for use in the detection, diagnosis, prevention and treatment of vial disease |
| 07/11/2002 | US20020090609 Diagnostics and therapy of diseases associated with HHV-8 infections |
| 07/11/2002 | US20020090607 Peptide; for use in the diagnosis and detection of viral disease |
| 07/11/2002 | US20020090382 Antiviral compounds and methods |
| 07/11/2002 | US20020090379 Poviding self-protein analog by molecular biological means by substitution of one or more peptide fragments of self-protein by corresponding number of peptides known to contain immunodominant foreign T-cell epitopes |
| 07/11/2002 | US20020090376 Administering to the animal bacterial cells having a mutated poxR gene for inducing immune response in animal |
| 07/11/2002 | US20020090374 Chimeric proteins with cell-targeting specificity and apoptosis-inducing activities |
| 07/11/2002 | US20020090373 ADAMTS polypeptides, nucleic acids encoding them, and uses thereof |
| 07/11/2002 | US20020090372 Isolated polypeptides used in vaccines and pharmaceuticals for treatment of prostate cancer |
| 07/11/2002 | US20020090371 Orally or enterally administering to the mammal an effective immunosuppressive dose of a plant material derived from a plant transformant capable of producing antigen or an immunosuppressive fragment or its derivative |
| 07/11/2002 | US20020090370 Novel porcine protein and uses thereof |
| 07/11/2002 | US20020090368 Therapeutic uses of bactericidal/permeability increasing (BPI) protein products |
| 07/11/2002 | US20020090366 Administering lymphotoxin beta receptor-alpha/beta heteromeric complex and a pharmaceutically acceptable carrier for therapy or reducing the advancement, severity or effects of neoplasia |
| 07/11/2002 | US20020090355 Reversal of cancer phenotype by inhibiting expression of prostate tumor inducing gene |
| 07/11/2002 | DE10064896A1 Schaltbare biochemische Pinzetten und synthetische Rezeptoren zur molekularen Organisation und Manipulation von Biomolekülen Switchable biochemical tweezers and synthetic receptors for molecular organization and manipulation of biomolecules |
| 07/11/2002 | DE10064434A1 Processing of lupin protein useful for producing lupin protein concentrate or isolate, comprises water extraction of an intermediate product comprising comminuted lupin material |
| 07/11/2002 | DE10061110A1 Expression der Keratingene 8 und 18 zur Therapie von Tumoren, insbesondere des Mammakarzinoms Expression of keratin genes 8 and 18 for the treatment of tumors, especially of breast cancer |
| 07/11/2002 | CA2708949A1 Immunizing compositions and methods of use |
| 07/11/2002 | CA2467434A1 Reversible mhc multimer staining for functional purification of antigen-specific t cells |
| 07/11/2002 | CA2434136A1 Mammalian tribbles signaling pathways and methods and reagents related thereto |
| 07/11/2002 | CA2434129A1 Degradation and detection of prion infectivity |
| 07/11/2002 | CA2433800A1 Antibodies to insulin-like growth factor i receptor |
| 07/11/2002 | CA2433782A1 Proteins and nucleic acids encoding same |
| 07/11/2002 | CA2433754A1 Alpha synuclein aggregation assays |
| 07/11/2002 | CA2433606A1 Amphipathic peptides and their use for transferring substances of interest into cells |
| 07/11/2002 | CA2433579A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 07/11/2002 | CA2433561A1 Compositions including gram negative siderophore receptor proteins and methods of use |
| 07/11/2002 | CA2433492A1 Transcription activation complex comprising arnt 1 to 3 and a transcriptional regulatory factor and uses thereof |
| 07/11/2002 | CA2433446A1 Inhibitors of memapsin 2 and use thereof |
| 07/11/2002 | CA2433236A1 Assay to determine efficacy of treatment for m. tuberculosis infection |
| 07/11/2002 | CA2433225A1 Isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof |
| 07/11/2002 | CA2433176A1 Mammalian cancer cell and transgenic mammal carrying human protooncogene and kit for diagnosing cancer using said protooncogene |
| 07/11/2002 | CA2432902A1 Gene disruption methodologies for drug target discovery |
| 07/11/2002 | CA2432853A1 Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs |
| 07/11/2002 | CA2432426A1 Recombinant protective protein from streptococcus pneumoniae |
| 07/11/2002 | CA2430667A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 07/11/2002 | CA2428932A1 Neuropilin homolog zcub5 |
| 07/10/2002 | EP1221489A1 Regulatory sequences functioning in filamentous fungi |
| 07/10/2002 | EP1221488A1 Stress proteins and uses therefor |
| 07/10/2002 | EP1221487A2 Polynucleotide molecules encoding neospora proteins |